139 related articles for article (PubMed ID: 9256945)
1. Prevention of Pneumocystis carinii pneumonia: who are we missing?
Schwarcz SK; Katz MH; Hirozawa A; Gurley J; Lemp GF
AIDS; 1997 Aug; 11(10):1263-8. PubMed ID: 9256945
[TBL] [Abstract][Full Text] [Related]
2. The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia.
Gallant JE; McAvinue SM; Moore RD; Bartlett JG; Stanton DL; Chaisson RE
Chest; 1995 Apr; 107(4):1018-23. PubMed ID: 7705108
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of preventing AIDS-related opportunistic infections.
Freedberg KA; Scharfstein JA; Seage GR; Losina E; Weinstein MC; Craven DE; Paltiel AD
JAMA; 1998 Jan; 279(2):130-6. PubMed ID: 9440663
[TBL] [Abstract][Full Text] [Related]
4. Clinic HIV-focused features and prevention of Pneumocystis carinii pneumonia.
Turner BJ; Markson L; Cocroft J; Cosler L; Hauck WW
J Gen Intern Med; 1998 Jan; 13(1):16-23. PubMed ID: 9462490
[TBL] [Abstract][Full Text] [Related]
5. Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.
Thea DM; Lambert G; Weedon J; Matheson PB; Abrams EJ; Bamji M; Straus WL; Thomas PA; Krasinski K; Heagarty M
Pediatrics; 1996 Jan; 97(1):59-64. PubMed ID: 8545225
[TBL] [Abstract][Full Text] [Related]
6. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
7. Discontinuation of chemoprophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection. HIV Outpatient Study (HOPS) Investigators.
Yangco BG; Von Bargen JC; Moorman AC; Holmberg SD
Ann Intern Med; 2000 Feb; 132(3):201-5. PubMed ID: 10651600
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of Pneumocystis carinii pneumonia in an era of effective prophylaxis: the relative contribution of non-adherence and drug failure.
Lundberg BE; Davidson AJ; Burman WJ
AIDS; 2000 Nov; 14(16):2559-66. PubMed ID: 11101068
[TBL] [Abstract][Full Text] [Related]
10. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
[TBL] [Abstract][Full Text] [Related]
11. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
; Mocroft A; Reiss P; Kirk O; Mussini C; Girardi E; Morlat P; Stephan C; De Wit S; Doerholt K; Ghosn J; Bucher HC; Lundgren JD; Chene G; Miro JM; Furrer H
Clin Infect Dis; 2010 Sep; 51(5):611-9. PubMed ID: 20645862
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
Torres RA; Barr M; Thorn M; Gregory G; Kiely S; Chanin E; Carlo C; Martin M; Thornton J
Am J Med; 1993 Dec; 95(6):573-83. PubMed ID: 8018144
[TBL] [Abstract][Full Text] [Related]
13. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group.
McNaghten AD; Hanson DL; Jones JL; Dworkin MS; Ward JW
AIDS; 1999 Sep; 13(13):1687-95. PubMed ID: 10509570
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /l.
Koletar SL; Heald AE; Finkelstein D; Hafner R; Currier JS; McCutchan JA; Vallee M; Torriani FJ; Powderly WG; Fass RJ; Murphy RL;
AIDS; 2001 Aug; 15(12):1509-15. PubMed ID: 11504983
[TBL] [Abstract][Full Text] [Related]
15. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
Fisher RG; Nageswaran S; Valentine ME; McKinney RE
AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767
[TBL] [Abstract][Full Text] [Related]
16. Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy.
Schneider MM; Borleffs JC; Stolk RP; Jaspers CA; Hoepelman AI
Lancet; 1999 Jan; 353(9148):201-3. PubMed ID: 9923876
[TBL] [Abstract][Full Text] [Related]
17. Geographic distribution of human immunodeficiency virus-associated Pneumocystis carinii pneumonia in San Francisco.
Morris AM; Swanson M; Ha H; Huang L
Am J Respir Crit Care Med; 2000 Nov; 162(5):1622-6. PubMed ID: 11069786
[TBL] [Abstract][Full Text] [Related]
18. Prescription of Pneumocystis Jiroveci Pneumonia Prophylaxis in HIV-Infected Patients.
Lin X; Garg S; Mattson CL; Luo Q; Skarbinski J
J Int Assoc Provid AIDS Care; 2016 Nov; 15(6):455-458. PubMed ID: 27629868
[TBL] [Abstract][Full Text] [Related]
19. Changes in hospital admissions pattern in patients with human immunodeficiency virus infection in the era of Pneumocystis carinii prophylaxis.
Chien SM; Rawji M; Mintz S; Rachlis A; Chan CK
Chest; 1992 Oct; 102(4):1035-9. PubMed ID: 1395739
[TBL] [Abstract][Full Text] [Related]
20. Insurance coverage, usual source of care, and receipt of clinically indicated care for comorbid conditions among adults living with human immunodeficiency virus.
Goldstein RB; Rotheram-Borus MJ; Johnson MO; Weinhardt LS; Remien RH; Lightfoot M; Catz SL; Gore-Felton C; Kirshenbaum S; Morin SF;
Med Care; 2005 Apr; 43(4):401-10. PubMed ID: 15778643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
